Research memoWuXi AppTec Co., Ltd. (2359.HK) · HKSEMemo of October 14, 2026

WuXi dividend

WuXi pays a dividend per share, with its history shown across five years. Its cash covered the dividend in 2025, with free cash flow and real free cash flow both positive.

1.67
Dividend paid per share, 2025
1.1%
Dividend yield
1.9%
Real free cash flow yield
2.0%
Free cash flow yield
Read the full WuXi memoYour first report is free · no card
Every number traced to WuXi's filings8 chapters · 17,282 words223 sources cited

How much does WuXi pay per share?

Dividend per share against free cash flow per share (RMB per share; shares in millions)0.30-1.0920210.52-0.2520220.902.0520231.002.4720241.673.362025Dividends paid, per shareReal free cash flow per share
ResultsRMB millions; per share in RMB
20252024202320222021
Revenue43,420.82435,766.745
Net income17,846.77811,266.369
EPS, diluted6.173.89
Dividend per share1.930.980.990.890.52

What this means. The 2025 dividend per share leaves out a separate special dividend, so shareholders received more than 1.93 RMB per share in total.

Does WuXi’s cash cover its dividend?

The cash position improved substantially after that investment phase. Free cash flow reached RMB10,600.072 million in 2025, allowing WuXi to fund dividends and share purchases more comfortably. Even so, payouts can exceed free cash flow when a company also uses existing cash, debt, asset sales or new equity.

Free cash flow was RMB10,600.072 million after capital spending, lease payments and interest. After RMB801.758 million of stock pay, real free cash flow was RMB9,798.314 million. Stock pay does not use cash immediately, but it gives employees part of the business’s value, so deducting it gives an owner-oriented view.

Follow the money: where the free cash flow wentRMB millions
20252024202320222021
Free cash flow10,600.0727,523.1686,815.617123.005-2,655.439
− Dividends paid4,875.1352,882.0512,649.0841,529.442892.98
− Share buybacks4,289.2443,908.9091,182.211960.2471,675.211
= Free cash flow not paid out1,391.693732.2082,984.322
= Paid out more than the free cash flow2,366.6845,223.63
Paid out, % of free cash flow86.5%90.3%56.2%2,024.1%not meaningful

What this means. In 2022 and 2021, the company paid shareholders more than its business generated, so it had to use savings or borrow money to cover the difference.

What could change WuXi’s dividend?

Base dividends rise from CNY2.70 per share to CNY3.15 and CNY3.66. The path uses the analyst EPS estimate of CNY9.032 and the board’s 30% payout policy, followed by moderate earnings growth. Bear dividends fall to CNY1.30 and then remain near CNY1.20 because weaker earnings and investment needs could reduce the payout. Bull dividends reach CNY2.85, CNY3.60 and CNY4.50 if demand and utilization sustain stronger EPS.

What is WuXi’s dividend yield today?

The dividend yield is 1.1%, so investors depend mainly on future growth. Enterprise value is 9.2 times revenue, while price to book is 6.1 times. That means the market expects customer relationships, scientific expertise, and new capacity to produce much more than the accounting assets alone.

What an investor pays todayHK$ millions; per share in HK$
Today (Oct 14, 2026)
Share price202.00
P/E, last 12 months (calculated)24.6x
Free cash flow yield (calculated)2.0%
Real free cash flow yield (calculated)1.9%
Dividend yield (calculated)1.1%

What this means. The business value is lower than the stock market value because the company has more cash and short-term investments than debt, reducing what a buyer would effectively pay.

From the full memo · 1. The business

To understand WuXi AppTec, follow a medicine from an idea to a factory and then follow the money through that journey. WuXi sells the scientific work, testing, development and manufacturing that drug companies need, while its economics depend on turning that work into repeat orders at a profit.

Continue reading, free
Your first report is free · no card

Where these numbers come from

More on WuXi

WuXi earnings

Its rivals

WuXi Biologics (2269.HK)IQVIA (IQV)Thermo Fisher Scientific (TMO)

Browse

All stocksHang Seng companiesCompanies W
The full WuXi memoYour first report is free
Read it